Investor Relations

Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area of oncology with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has promising product candidates in clinical and late preclinical development and has entered into strategic collaborations with leading global pharmaceutical companies.

Recent News > MORE
Date Title  
Thursday, December 1, 2016 Five Prime Presents Data from FPA144 in Urothelial Cancer at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapies
Wednesday, November 30, 2016 Five Prime Therapeutics to Host Research & Development Day on December 8, 2016
Upcoming and Recent Events > MORE
Date Title  
Thursday, December 8, 2016
8:00 AM ET
Five Prime Therapeutics Research & Development Day
Location New York City, NY
Monday, November 7, 2016
2:00 PM MT
Credit Suisse 25th Annual Healthcare Conference
Location The Phoenician
Scottsdale , AZ
Supporting Materials
PDF Corporate Overview   2.1 MB   Add to Briefcase
Thursday, November 3, 2016
4:30 PM ET
Five Prime Therapeutics, Inc. 2016 Q3 Quarterly Earnings Call
Supporting Materials
PDF Corporate Overview  782.4 KB   Add to Briefcase

FPRX (Common Stock)

Change (%)

Data as of 4:00 PM ET on Friday, December 2, 2016
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.